Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

Multiple Sclerosis

(2018) Daniel S. Reich et al.   NEW ENGLAND JOURNAL OF MEDICINE

CSF β-amyloid predicts prognosis in patients with multiple sclerosis

(2018) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis

(2016) Benedetta Bodini et al.   ANNALS OF NEUROLOGY

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

(2016) Anna M Pietroboni et al.   Multiple Sclerosis Journal

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

(2016) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging

(2016) Jordi A. Matías-Guiu et al.   Frontiers in Neurology

Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study

(2015) Jordi A. Matías-Guiu et al.   BMC Neurology

Role of amyloid-β CSF levels in cognitive deficit in MS

(2015) Antonietta Gentile et al.   CLINICA CHIMICA ACTA

BREMSO: a simple score to predict early the natural course of multiple sclerosis

(2015) R. Bergamaschi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies

(2015) E. Grecchi et al.   JOURNAL OF NUCLEAR MEDICINE

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Advanced imaging tools to investigate multiple sclerosis pathology

(2015) Benedetta Bodini et al.   PRESSE MEDICALE

Reduced retention of Pittsburgh compound B in white matter lesions

(2014) Lidia Glodzik et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter

(2014) L. Glodzik et al.   NEUROIMAGE

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Multiple sclerosis: Lessons from molecular neuropathology

(2013) Hans Lassmann   EXPERIMENTAL NEUROLOGY

The Rao’s Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population

(2013) B. Goretti et al.   NEUROLOGICAL SCIENCES

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

(2012) Kristin Augutis et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

(2011) Adam S. Fleisher   ARCHIVES OF NEUROLOGY

An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

(2011) Paul Schmidt et al.   NEUROIMAGE

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4′-methylaminophenyl)- 6-hydroxybenzothiazole

(2010) Bruno Stankoff et al.   ANNALS OF NEUROLOGY

An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis

(2010) Mario Mangiardi et al.   BRAIN PATHOLOGY

Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis

(2010) Francesco Mori et al.   NEUROPSYCHOPHARMACOLOGY

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

(2009) N Mattsson et al.   Multiple Sclerosis Journal

Remyelination in the CNS: from biology to therapy

(2008) Robin J. M. Franklin et al.   NATURE REVIEWS NEUROSCIENCE